COVID-19 and Cardiovascular Diseases.

Area of Science:

• Cardiology
• Infectious Diseases
• Internal Medicine

Background:

• Coronavirus disease 2019 (COVID-19) presents significant challenges for cardiovascular disease (CVD) patients.
• Understanding the interplay between COVID-19 and various cardiovascular conditions is crucial for effective management.

Purpose of the Study:

• To provide an up-to-date overview of cardiovascular disease in the context of COVID-19.
• To highlight acute myocardial injury, its pathophysiology, diagnosis, and treatment.
• To discuss associations between hypertension and COVID-19, coronary artery disease management, arrhythmias, coagulopathies, and cardiopulmonary resuscitation protocols.

Main Methods:

• Literature review synthesizing current information on COVID-19 and cardiovascular disease.
• Analysis of pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic strategies.
• Exploration of drug-drug interactions between COVID-19 treatments and cardiovascular medications.

Main Results:

• COVID-19 can cause acute myocardial injury with distinct pathophysiology and clinical presentations.
• Hypertension is associated with increased risk and severity in COVID-19 patients.
• Management strategies for acute coronary syndromes, arrhythmias, and venous thromboembolism in COVID-19 patients are outlined.
• Drug-drug interactions require careful consideration for optimal patient care.

Conclusions:

• COVID-19 significantly impacts cardiovascular health, necessitating a comprehensive understanding of its effects.
• Evidence-based recommendations for managing cardiovascular complications in COVID-19 patients are essential.
• This review consolidates critical information for clinicians managing cardiovascular disease during the pandemic.